LY3537021 for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Sep 2025: Trial registered, NCT07169851
  2. 28 Nov 2025: Trial started, NCT07169851

The trials

NCT07169851: A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

State
Under way
Phase
Phase 2
People
204 planned
Started
28 Nov 2025
Primary completion
Dec 2026
Arms
LY3537021 + Antiemetic Therapies
Results
None posted
  1. 12 Sep 2025: Trial registered
  2. 28 Nov 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.